1. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994. 31:1–19.
2. Curth HO. Dermatoses and malignant internal tumors. AMA Arch Derm. 1955. 71:95–107.
3. Lee SS, Jung NJ, Im M, Lee Y, Seo YJ, Lee JH. Acral-type malignant acanthosis nigricans associated with gastric adenocarcinoma. Ann Dermatol. 2011. 23:S208–S210.
4. Lee NH, Choi EH, Lee WS, Ahn SK. A case of familial acanthosis nigricans. Korean J Dermatol. 1997. 35:802–804.
5. Yu HD, Kim NI, Sim WY, Kim YS, Haw CR. Syndromal acanthosis nigricans with insulin resistance. Korean J Dermatol. 1992. 30:411–417.
6. Elder DE, Elenitsas R, Johnson BL Jr, Murphy GF, Xu X. Lever's histopathology of the skin. 2009. 10th ed. Philadelphia (PA): Lippincott Williams & Wilkins.
7. Gross G, Pfister H, Hellenthal B, Hagedorn M. Acanthosis nigricans maligna. Clinical and virological investigations. Dermatologica. 1984. 168:265–272.
8. Grasinger CC, Wild RA, Parker IJ. Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women. Fertil Steril. 1993. 59:583–586.
9. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989. 87:269–272.
10. El Safoury OS, Shaker OG, Fawzy MM. Skin tags and acanthosis nigricans in patients with hepatitis C infection in relation to insulin resistance and insulin like growth factor-1 levels. Indian J Dermatol. 2012. 57:102–106.
11. Lee JH, Kim MY, Kim HO, Park YM. Nevoid acanthosis nigricans localized to the umbilicus: successful treatment with topical tretinoin. Ann Dermatol. 2005. 17:24–26.
12. Ozdemir M, Toy H, Mevlitoğlu I, Demirkesen C. Generalized idiopathic acanthosis nigricans treated with acitretin. J Dermatolog Treat. 2006. 17:54–56.